Thromboangiitis Obliterans
📧 Sign up to get email alerts when something new happens for Thromboangiitis Obliterans.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease
An individual patient expanded access IND for Selexipag (Uptravi) in participants with non-healing wounds due to Thromboangiitis Obliterans …
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers [Phase 1]
First-in-human Phase 1 single ascending dose study of ATI-1013 in healthy smokers, investigating treatment for Thromboangiitis Obliterans (B…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Stempeucel in patients with critical limb ischemia due to thromboangiitis oblit…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
A follow-up gene therapy trial for critical limb ischemia is currently enrolling by invitation, sponsored by Beijing Northland Biotech Co., …
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease [Phase 3]
Phase 3 clinical trial evaluating botulinum toxin type A for Thromboangiitis Obliterans (Buerger's disease) and Raynaud phenomenon; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) [Phase 2]
Phase 2 study evaluating CLBS12 for critical limb ischemia has completed. The update covers the trial status in patients with related vascul…
-
CLINICAL_TRIALS withdrawal · 2017-04-07Clinical Trial Update: A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease [Phase 2]
The Phase 2 trial evaluating Stempeucel for critical limb ischemia due to Buerger's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease
The trial ADDICTAO investigating psychological and addictive profiles in patients with Thromboangiitis Obliterans (Buerger's disease) has co…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan
The document reports the completed status of a clinical trial testing bosentan for thromboangiitis obliterans (Buerger's disease).
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia [Phase 1, Phase 2]
This document is a clinical trial update on the use of adipose-derived regenerative cells to treat critical limb ischemia in Phase 1/2, with…
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia [NA]
A clinical trial compares purified CD34+ cell therapy to peripheral blood mononuclear cells for treating critical limb ischemia, sponsored b…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Contrast Enhanced Ultrasound and Muscle [NA]
Clinical trial NCT02128750, assessing Contrast Enhanced Ultrasound and Muscle, has completed at University Hospital, Grenoble, with conditio…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of autologous bone marrow mononuclear cells processed by two methods in patien…